Tohru Ishikawa Selected Research

Pharmaceutical Preparations

2/2003

[Optimal dosing schedule in combination therapy with irinotecan and doxifluridine in a human colorectal cancer xenograft model].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tohru Ishikawa Research Topics

Disease

11	Neoplasms (Cancer) 02/2014 - 02/2003
2	Neoplasm Metastasis (Metastasis) 02/2014 - 02/2010
2	Squamous Cell Carcinoma of Head and Neck 02/2012 - 01/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2010 - 02/2010
2	Infections 09/2008 - 01/2006
2	Chronic Hepatitis B 09/2008 - 01/2006
2	Colorectal Neoplasms (Colorectal Cancer) 09/2003 - 02/2003
1	Bone Diseases (Bone Disease) 02/2014
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 02/2014
1	Hypercalcemia (Milk Alkali Syndrome) 02/2014
1	Multiple Myeloma 02/2014
1	Dysgeusia (Parageusia) 08/2013
1	Taste Disorders (Taste Disorder) 08/2013
1	Chronic Hepatitis C 05/2011
1	Breast Neoplasms (Breast Cancer) 03/2009
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2008
1	Hemosiderosis 09/2008
1	Siderosis 09/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2008
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 07/2006
1	Hypoxia (Hypoxemia) 07/2006
1	Papillary Carcinoma 07/2006
1	Hepatitis 01/2006
1	Stomach Neoplasms (Stomach Cancer) 07/2005
1	Lymphatic Metastasis 01/2004
1	Mouth Neoplasms (Oral Cancer) 01/2004
1	Melanoma (Melanoma, Malignant) 01/2004
1	Diarrhea 02/2003

Drug/Important Bio-Agent (IBA)

3	Fluorouracil (Carac)FDA LinkGeneric 07/2005 - 03/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2013 - 07/2005
2	Docetaxel (Taxotere)FDA Link 08/2013 - 07/2005
2	Chemokine ReceptorsIBA 03/2009 - 01/2006
2	lipoarabinomannan (LAM)IBA 09/2008 - 01/2006
2	Lamivudine (Epivir)FDA Link 09/2008 - 01/2006
2	ChemokinesIBA 01/2006 - 01/2004
2	doxifluridineIBA 07/2005 - 02/2003
2	Thymidine PhosphorylaseIBA 07/2005 - 03/2003
2	5-vinyluracilIBA 09/2003 - 03/2003
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2003 - 03/2003
2	Capecitabine (Xeloda)FDA Link 09/2003 - 03/2003
2	2',3'- O- diacetyl- 5'- deoxy- 5- vinylcytidineIBA 09/2003 - 03/2003
1	Diphosphonates (Bisphosphonates)IBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Ribavirin (Virazole)FDA LinkGeneric 05/2011
1	peginterferon alfa-2b (Pegintron)FDA Link 05/2011
1	InterferonsIBA 05/2011
1	adhesion receptorIBA 04/2010
1	CollagenIBA 04/2010
1	Collagen Type I (Type I Collagen)IBA 04/2010
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2010
1	Cadherins (E-Cadherin)IBA 02/2010
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2010
1	Oxygen (Dioxygen)IBA 03/2009
1	Ferritins (Ferritin)IBA 09/2008
1	IronIBA 09/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Proto-Oncogene Proteins c-metIBA 07/2006
1	taxaneIBA 07/2005
1	Taxoids (Taxanes)IBA 07/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2004
1	Vascular Endothelial Growth Factor CIBA 01/2004
1	Complementary DNA (cDNA)IBA 09/2003
1	eniluracilIBA 09/2003
1	EsterasesIBA 03/2003
1	Cytidine DeaminaseIBA 03/2003
1	EnzymesIBA 03/2003
1	ProdrugsIBA 03/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2003
1	Pharmaceutical PreparationsIBA 02/2003

Therapy/Procedure

4	Therapeutics 05/2011 - 02/2003
1	Drug Therapy (Chemotherapy) 08/2013
1	Free Tissue Flaps 03/2011